301235 Stock Overview
Engages in the research and development, design, implementation, operation, and maintenance of medical purification integrated systems in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 1/6 |
Wuhan Huakang Century Medical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥16.99 |
| 52 Week High | CN¥28.57 |
| 52 Week Low | CN¥14.03 |
| Beta | 0.58 |
| 11 Month Change | -5.72% |
| 3 Month Change | -10.39% |
| 1 Year Change | -21.60% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.56% |
Recent News & Updates
Shareholder Returns
| 301235 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -5.5% | -2.8% | -1.1% |
| 1Y | -21.6% | -13.5% | -17.4% |
Return vs Industry: 301235 underperformed the CN Medical Equipment industry which returned -13.5% over the past year.
Return vs Market: 301235 underperformed the CN Market which returned -17.4% over the past year.
Price Volatility
| 301235 volatility | |
|---|---|
| 301235 Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 5.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 301235 has not had significant price volatility in the past 3 months.
Volatility Over Time: 301235's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,921 | Xinqiang Xie | www.whhksj.com.cn |
Wuhan Huakang Century Medical Co., Ltd. engages in the research and development, design, implementation, operation, and maintenance of medical purification integrated systems in China and internationally. It also sells medical equipment and consumables.
Wuhan Huakang Century Medical Co., Ltd. Fundamentals Summary
| 301235 fundamental statistics | |
|---|---|
| Market cap | CN¥1.79b |
| Earnings (TTM) | CN¥92.57m |
| Revenue (TTM) | CN¥1.59b |
19.4x
P/E Ratio1.1x
P/S RatioIs 301235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301235 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.59b |
| Cost of Revenue | CN¥987.60m |
| Gross Profit | CN¥603.46m |
| Other Expenses | CN¥510.89m |
| Earnings | CN¥92.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 37.93% |
| Net Profit Margin | 5.82% |
| Debt/Equity Ratio | 32.6% |
How did 301235 perform over the long term?
See historical performance and comparison